
Connecting Global Health Innovators with Boston’s Life Sciences Ecosystem
During a two-week immersion program in Boston, taking place from November 12–21, 2025, selected biotech, medtech, and digital health companies will have the opportunity to build meaningful relationships with key players in the innovation ecosystem — including investors, industry leaders, advisors, and both public and private institutions.
Your Gateway to Growth in the U.S. Life Sciences Market
An immersive experience designed to equip companies with the knowledge, tools, and connections to accelerate their growth. Participants gain practical guidance in market analysis, business development, fundraising, and networking with key players across Boston’s innovation ecosystem.
The program also offers strategic support to help companies successfully enter the U.S. market, providing the know-how to establish operations and build meaningful partnerships in a competitive landscape.
Program Sessions
-
Setting the stage for participants, providing them with a warm introduction to the vibrant innovation ecosystem of Boston, highlighting key players, industry trends, and opportunities available.
-
Insights and strategies for approaching stakeholders in Boston's innovation ecosystem, addressing cultural aspects and best practices for initiating conversations and building relationships.
-
An interactive session where participants pitch their projects in 5 minutes, receiving feedback. It guides participants in creating and delivering effective pitches tailored for a US audience, emphasizing the importance of a compelling core story beyond the investor deck and elevator pitch.
-
Lectures, discussions, and experiential learning led by a Harvard and MIT lecturer. Participants gain valuable negotiation skills through demos, exercises, and role-plays.
-
Insights into why Boston is recognized as the world's leading life sciences ecosystem. Participants will discover how their businesses can maximize the benefits of this supercluster and capitalize on the opportunities it presents.
-
Understanding of the intricacies of the US healthcare system and reimbursement landscape. This session explores key aspects of the system, including reimbursement models, regulations, and market dynamics.
-
Interactive sessions with successful founders who have transitioned their ventures to the US. Participants will hear firsthand stories and insights about the challenges, opportunities, and lessons learned during the process.
-
Engaging in discussions with experienced US investors. Participants will gain valuable insights into the investor's perspective, investment strategies, and trends in the biotech, med-tech, and digital health sectors.
-
Essential tips and insights for a successful market entry. Led by an experienced accelerator assisting foreign startups, this session covers crucial considerations when landing in the US, offering practical guidance for launching in the region.
-
Concise legal guidance for preparing a company to establish a presence in the United States.
-
Companies have several 20-minute meetings with experts who provide feedback and advice on their strategy, including hypotheses validation, road to market, business strategy, clinical trials, reimbursement, and more.
-
Guidance on creating a compelling investor deck for the US market. Participants will learn strategies to highlight key elements and attract US investors, including market potential, competition analysis, business model, and financial projections.
-
Strategies for non-US-based companies to commercialize, expand internationally, and market breakthrough innovations in the US. Participants gain insights on the best approaches and navigating the unique dynamics of the US market.
-
This session covers key aspects of immigration law, visa requirements, and processes for individuals and companies.
-
Key aspects of healthcare regulations, compliance requirements, and industry standards, providing participants with valuable insights into the regulatory landscape.
-
Guidance on securing non-dilutive funding in the United States. Participants will learn strategies, tips, and best practices for accessing grants, government funding, and other non-equity sources of financing.
-
Companies have several 20-minute meetings with investors to present their ventures, receive feedback, explore investment opportunities, and build relationships.
-
One-on-one meetings to address the specific regulatory needs of startups. Participants can discuss their cases and receive guidance on FDA regulations and compliance.
-
Non-traditional fundraising avenues for startups through collaborations with foundations. Participants will delve into a case study highlighting successful partnerships between foundations and startups.
-
Insights and tours into the various accelerators and incubators available in Boston. Participants will learn about the different programs, resources, and support offered by these organizations to foster the growth and development of startups.
-
Opportunities to connect, collaborate, and build relationships with industry peers, experts, investors, and key stakeholders within Boston's innovation ecosystem, culminate with a final pitch in a celebratory atmosphere to a diverse audience.
Participants Profile
Richi Lifesciences welcomes global companies operating in biotech, medtech, diagnostics, or digital health that are driven by innovation and impact. Our participants are backed by robust scientific or technological validation and possess a clear, differentiated value proposition. Visionary and capable teams lead them with the skills to execute, the ambition to scale, and the commitment to address pressing global health challenges. Companies are positioned for financial growth but also equipped with a clear vision for international expansion and adaptability.
Richi Lifesciences is also open to selected stakeholders from around the world, allowing them to observe and shadow sessions designed for participant companies. This provides an opportunity for them to engage in activities that foster connections and gain valuable insights into Boston's Innovation Ecosystem.
Pharma Executives | Investors | Incubators and Accelerators | Technology Transfer Offices | Government Agencies | Specialized Service Providers